Stoke Therapeutics (STOK) EBT Margin Growth (1y) (2023 - 2026)
Stoke Therapeutics (STOK) EBT Margin Growth (1y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1,526.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 452.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Stoke Therapeutics | 1.87 Bn | 1.53 Bn | - | -87,474.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -87,474.00 |
| Dec 31, 2025 | -438,816.00 |
| Sep 30, 2025 | 16,735.00 |
| Jun 30, 2025 | 36,192.00 |
| Mar 31, 2025 | 69,756.00 |
| Dec 31, 2024 | 574,384.00 |
| Sep 30, 2024 | 28,141.00 |
| Jun 30, 2024 | 96,316.00 |
| Mar 31, 2024 | -14,593.00 |
| Dec 31, 2023 | -199,789.00 |
| Sep 30, 2023 | 18,639.00 |
| Jun 30, 2023 | -49,888.00 |
| Mar 31, 2023 | 38,686.00 |